- Home
- SMTI vs DSAC Comparison
SMTI vs DSAC Comparison
Compare SMTI & DSAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SMTI | DSAC |
|---|---|---|
| Founded | 1982 | 2025 |
| Country | United States | United Kingdom |
| Employees | 108 | N/A |
| Industry | Medical/Dental Instruments | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 313.5M | 345.6M |
| IPO Year | 2008 | N/A |
Fundamental Metrics
Financial Performance| Metric | SMTI | DSAC |
|---|---|---|
| Price | $34.11 | $10.18 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $34.00 | N/A |
| AVG Volume (30 Days) | ★ 293.1K | 86.9K |
| Earning Date | 05-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.05 | N/A |
| Revenue | ★ $15,586,976.00 | N/A |
| Revenue This Year | $17.31 | N/A |
| Revenue Next Year | $12.48 | N/A |
| P/E Ratio | $681.80 | ★ N/A |
| Revenue Growth | ★ 32.47 | N/A |
| 52 Week Low | $16.05 | $9.90 |
| 52 Week High | $35.70 | $10.47 |
Technical Indicators
Market Signals| Indicator | SMTI | DSAC |
|---|---|---|
| Relative Strength Index (RSI) | 82.74 | 66.86 |
| Support Level | $20.47 | $9.90 |
| Resistance Level | N/A | $10.47 |
| Average True Range (ATR) | 0.94 | 0.01 |
| MACD | 0.73 | -0.00 |
| Stochastic Oscillator | 97.49 | 100.00 |
Price Performance
Historical ComparisonAbout SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.
About DSAC Daedalus Special Acquisition Corp. Class A Ordinary Shares
Daedalus Special Acquisition Corp is a blank check company.